NIH-funded research NIH-funded research

A new test using gut bacteria to assess prostate cancer risk

Official title: TOPIC NUMBER: 458 SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE IONCOBIOMIX: MICROBIOME-BASED TEST FOR PROSTATE CANCER RISK

Funded at Oncobiomix INC. · NIH-11195264 · Data updated 2026-11-12

This study is looking at how the bacteria in your gut might help us better understand your risk of prostate cancer, and if you join, you could help create a new test that could catch prostate cancer earlier and reduce the need for extra procedures.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOncobiomix INC.
NIH-funded
Lab location1 site (San Antonio, United States)
Project startSeptember 11, 2024
Project endSeptember 10, 2025
Funding year2024
Award (this year)$400,000
NIH project number75N91024C00067-0-9999-1
Project IDNIH-11195264 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are men at risk for prostate cancer or those undergoing prostate cancer screening.

Less likely to help

Patients who have already been diagnosed with advanced prostate cancer may not benefit from this research.

What this research studies

This research investigates a novel approach to assess the risk of prostate cancer by analyzing the gut microbiome. It aims to develop a microbiome signature score that evaluates specific gut bacteria associated with prostate cancer, providing a more accurate risk assessment compared to traditional PSA testing. The study will establish a standard operating procedure for this microbiome test, facilitating its clinical validation and potential commercialization. Patients participating in this research may contribute to the development of a tool that could improve early detection of prostate cancer while reducing unnecessary procedures.

Why it matters

Potential benefit: If successful, this research could lead to a more accurate and less invasive method for assessing prostate cancer risk.

How similar studies have gone: Other research has shown promise in using microbiome analysis for cancer risk assessment, indicating potential success for this novel approach.

Where this research is happening

  • Oncobiomix INC.
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Leach, Charles — Oncobiomix INC.
  • Study coordinator: Leach, Charles

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.